Derek Lowe – Page 8
-
Opinion
Column: In the pipeline
The map of scientific disciplines is growing ever more complex. Derek Lowe surveys the country
-
Opinion
Column: In the pipeline
'Natural products are back!' is a headline Derek Lowe has seen several times before
-
Opinion
Column: In the pipeline
Drug discovery is an inherently risky business. Derek Lowe tries to balance some of the risk equations
-
Opinion
Column: In the pipeline
Enzymes have been giving chemists inferiority complexes since day one, says Derek Lowe. But there's no denying their potential
-
Opinion
Column: In the pipeline
Some medicinal chemists can't get enough fluorines in their molecules. Derek Lowe explains the love-hate relationship
-
Opinion
Column: In the pipeline
Who's that asleep at the back? Don't be too quick to blame yourself when tedious talks and soporific seminars fail to inspire, says Derek Lowe
-
Opinion
Column: In the pipeline
Should companies focus on big markets and the blockbuster dream? The more modern approaches are not without risks, says Derek Lowe
-
Opinion
Column: In the pipeline
Derek Lowe investigates the comeback combinatorial chemistry has made in the field of drug discovery
-
Opinion
Column: In the pipeline
Derek Lowe considers the quandaries of living in the age of the kinase
-
Opinion
Column: In the pipeline
Derek Lowe reminisces about lost laboratory techniques and wonders which will be next to go
-
Opinion
Column: In the pipeline
Derek Lowe looks into his crystal ball to see what the future of medicinal chemistry might be
-
Opinion
Column: In the pipeline
Derek Lowe wonders whether tagging molecules with fluorescent labels for assay is like tracking the members of a shoal of fish by tying each one to a whale
-
Opinion
Column: In the pipeline
Derek Lowe waxes lyrical about the joys of the electronic lab notebook
-
Opinion
Column: In the pipeline
Derek Lowe wonders whether peer-reviewed papers or patents are more reliable
-
Opinion
Column: In the pipeline
Derek Lowe takes a look back over his 20 years as a medicinal chemist
-
Opinion
Column: In the pipeline
Is the pharmaceutical industry churning out copycat versions of existing therapies? Derek Lowe dispels a few myths about 'me-too' drugs
-
Opinion
Column: In the pipeline
Derek Lowe advises opening your mind during the screening cascade taken by potential drug targets, and remaining goal orientated at all times
-
Opinion
Column: In the pipeline
Derek Lowe discusses the problem of leaning too heavily on favourite reactions